Skip to main content

MARSHALL WACE, LLP

Position in IRWD — Ironwood Pharmaceuticals Inc

CIK 1318757 LONDON, X0

Position in IRWD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,061,290
+$2,178,316 QoQ
Shares Held
4,290,093
-5.2% QoQ
Ownership
2.60%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 212 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in IRWD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. IRWD ranks #9 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IRWD

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,061,290 4,290,093
2026-03-31 $15,882,974 4,525,064
2025-12-31 $14,908,886 4,424,002
2025-09-30 $4,118,821 3,144,139
2025-06-30 $2,875,361 3,993,557
2025-03-31 $819,555 557,521
2024-06-30 $1,416,261 217,218
2024-03-31 $4,986,475 572,500
2023-12-31 $3,292,660 287,820
2023-09-30 $1,422,784 147,745
2021-06-30 $5,390,856 418,870
2021-03-31 $149,253 13,350
2020-09-30 $1,565,015 174,084
2020-06-30 $1,162,486 112,644
2020-03-31 $1,698,106 168,296